Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF DECEMBER 10, 2010 FBO #3303
MODIFICATION

B -- Centralized Chemopreventive Agent Repository and Chemistry Support

Notice Date
12/8/2010
 
Notice Type
Modification/Amendment
 
NAICS
541690 — Other Scientific and Technical Consulting Services
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 1050, Frederick, Maryland, 21702, United States
 
ZIP Code
21702
 
Solicitation Number
SS-PCPSB-5003-44
 
Point of Contact
Rukshani Fernnado, Phone: 3014353783, Virginia DeSeau, Phone: 301-435-3978
 
E-Mail Address
rf212s@nih.gov, vd9t@nih.gov
(rf212s@nih.gov, vd9t@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is an amendment to provide clarification and to extend the due date to December 20, 2010 by 3:00pm. The following additional information is provided as a result of questions asked: Technical Approach b. Demonstration of an understanding of preclinical and clinical study support needs 1.Can you please clarify NIH's intent with this experience/expertise requirement? This information will be addressed in the RFP. c. Experience in delivery of biological materials and laboratory services 2. What are the analytical instrumentation and services being requested? Research materials will have specifications with analytical testing required for stability testing, periodic testing, acceptance testing and release testing. Typical instrumentation required for pharmaceutical analysis includes UV-VIS, HPLC, IR, GC, dissolution apparatus and other specialty testing as needed. This testing may be obtained through subcontracted analytical services. 3. Are you requesting the service provider to acquire the clinical material or are you requesting the experience in the receipt process of biological materials? The service provider will be required to obtain research materials through a variety of mechanisms including custom synthesis and biotech processes. Facilities d. Separate office, preclinical, clinical, laboratory, quarantine, storage and shipping/receiving areas 1. Is the service provider required to have a preclinical and a clinical facility or the ability to store preclinical and clinical material and to provide such material to a preclinical and clinical facility? The pre-clinical and clinical materials must be stored separately although they may be housed in the same facility.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF/SS-PCPSB-5003-44/listing.html)
 
Record
SN02340363-W 20101210/101208233926-1d1098a2fb832213a25460901b11cd16 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.